Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Crazy Ones - The Explorers

https://skrr.ca/ 2020 has seen incredible work done in Saskatchewan by Taiga Gold, MAS Gold, SSR Mining and SKRR Exploration. Well, we are just getting started. SKRR is going to start drilling the Leland Gold project in the Trans Hudson Corridor within two weeks. A...
Featured Submission | January 13, 2021 |

Kinross Gold, Osino Resources, Scottie Resources - why now is the right time

It seems as if it has already been decided that the gold price will soon hit the USD 2,000.00 mark. This price is now only symbolic in character, as the precious metal is already at an all-time high and its value continues to rise. Due to the increase in the money supply by th...
Mario Hose | July 30, 2020 |

Surging Retail Sales, Cautious Powell, and Gold

Retail sales came in really strong in May, which could strengthen risk appetite, but the dovish Fed should support gold. However, the sales were still 6 percent lower than a year ago, which means that the coronavirus crisis has not ended yet. But such reports may, neve...
Arkadiusz Sieron | June 18, 2020 |

The Barriers to Investing in Private Equity Are Too High

The rich are getting richer and the poor are getting poorer, and for that we can largely blame policies of envy that increasingly restrict investors’ access to wealth-building instruments. Case in point: I was recently invited to participate in a pri...
Frank Holmes | October 15, 2019 |

Relmada Therapeutics Stock Soars on Phase 2 Depression Study Results

Shares of Relmada Therapeutics have traded wildly today after it announced Phase 2 results for its anti-depressant drug dextromethadone. The firm's shares have traded 100–200% higher today and the stock was halted several times trading due to extreme price volatility. ...
Streetwise Reports | October 16, 2019 |

Will Repogeddon Make Gold Rally?

One of the most important recent developments in the world of finance was the September liquidity crisis in the U.S. repo market. As a reminder, the repo market is where borrowers borrow cash from lenders against collateral in the form of safe securities such as government bon...
Arkadiusz Sieron | November 8, 2019 |

March is Critical for Commodity Markets and Coronavirus

Last Updated on Gold soared above $1,600 per ounce this week. The US dollar continues to remain ultra-strong and the US stock markets are at record highs. The flight to safety is in full effect and Bernie Sanders hasn’t even won the Democr...
Marin Katusa | February 21, 2020 |

Gold to Silver Ratio Hits 100!

Gold is testing its previous 2020 highs, but silver plunged anyway, which created a very special situation. Namely, the gold to silver ratio just jumped to the 100 level. This may not seem like a big deal, because ultimately people buy metals, not their ratio, but i...
Przemyslaw Radomski, CFA | March 10, 2020 |

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Shares of Immunomedics opened 117% higher after the company reported that it has stopped its Phase 3 ASCENT study of sacituzumab govitecan after recording "compelling evidence of efficacy" in heavily pretreated patients with metastatic triple-negative breast cancer. ...
Streetwise Reports | April 7, 2020 |

Novavax Announces Its First-in-Human Coronavirus Vaccine Trial Will Begin in Mid-May

Shares of Novavax traded 20% higher setting a new 52-week high price after the company reported that it has accelerated initiation of a Phase 1 clinical trial for its coronavirus vaccine candidate NVX-CoV2373. The study will commence in mid-May with preliminary results expec...
Streetwise Reports | April 9, 2020 |
1 2 3